Delivery Order SPE2DB22D1106-SPE2DB25FEKW2

Award Date 4/28/25
Potential Completion Date 5/19/25
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,117.58, is for the delivery of 4,567,914,248 units of the prescription medication Erleada 60 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 6, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,352.49, is for the supply of a specific pharmaceutical product, Erleada 240 mg tablets, with a performance period through May 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,352.49, is for the delivery of 4,568,076,666 units of the prescription medication Erleada 240 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,106.87 firm-fixed-price contract is for the supply of 4,564,519,776 tablets of the prescription medication Erleada 60 mg. The contract has an ultimate completion date of May 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,213.74 firm-fixed-price contract is for the delivery of Erleada 240 mg tablets, a specialty medication. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,352.49, is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price, delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the medication Erleada 60 mg Tablet. The contract has a ceiling value of $7,306.27 and an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,106.87, is for the provision of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract is a firm fixed price delivery order with a period of performance through May 26, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $21,918.81 firm fixed-price contract is for the supply of 4,565,953,510 tablets of the prescription drug Erleada 60 mg. The contract has an ultimate completion date of October 18, 2024. This award is a part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,558.78, is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a period of performance through April 2, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEKW2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,235.16, is for the delivery of the prescription medication Erleada 60 mg tablets. The contract has a firm fixed price pricing type and a completion date of May 19, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is one of many that can be issued under the larger IDC contract.

Generated 7/28/25, 11:04 AM